BioSpace News Archive

Drug Development

Alizé Pharma Launches Phase 2 Clinical Trial Of AZP-531 In Prader-Willi Syndrome

March 2, 2015
·
5 min read
Polar Helps Make Healthy Lifestyle Choices With MyFitnessPal

March 2, 2015
·
3 min read
InMed To Present Investor Webcast March 5

March 2, 2015
·
2 min read
FDA

Alere Receives IVD CE Mark For Alere Q HIV-1/2 Detect Assay For Molecular Diagnosis Of HIV At The Point Of Care

March 2, 2015
·
5 min read
Policy

Pacira Pharmaceuticals, Inc. Receives Complete Response Letter From FDA For sNDA Seeking Approval Of EXPAREL Use In Nerve Block To Provide Postsurgical Analgesia

March 2, 2015
·
5 min read
Drug Development

Transition Therapeutics Inc. Announces Enrolment Completion Of ELND005 Phase 2 Clinical Study In Agitation And Aggression In Patients With Alzheimer’s Disease

March 2, 2015
·
3 min read
Biotech Beach

Mast Therapeutics Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure

March 2, 2015
·
8 min read
Taiho Pharmaceutical Submits TAS-102 Marketing Authorisation Application To The European Medicines Agency For The Treatment Of Refractory Metastatic Colorectal Cancer

March 2, 2015
·
5 min read
Drug Development

Oncolytics Biotech Inc. Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Cancer Of The Fallopian Tube

March 2, 2015
·
4 min read
Drug Development

Portola Pharmaceuticals, Inc. Announces Full Results From Positive Phase 3 ANNEXA-R Study Demonstrating That Andexanet Alfa Rapidly And Significantly Reversed Anticoagulant Effect Of Factor Xa Inhibitor XARELTO

March 2, 2015
·
11 min read